Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
IBEX Limited

IBEX Limited (IBEX) Stock Overview

Explore IBEX Limited’s financial performance, market position, analyst ratings, and future outlook.

IBEX●NASDAQ
TechnologyInformation Technology Services
$40.20
$0.72(1.76%)
U.S. Market opens in 23h 56m

IBEX Limited (IBEX)

Meyka AI Score

Z

Key Financials

Market Cap538.2M
P/E Ratio11.63
EPS (TTM)$3.55
ROE0.29%
Fundamental Analysis

AI Price Forecasts

1 Month$52.46
3 Months$39.09
1 Year Target$40.37

IBEX Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of IBEX Limited (NASDAQ: IBEX) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, IBEX Limited's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of IBEX on the NASDAQ shows an RSI of 61.63, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $40.37 for the NASDAQ listing.

Key metrics behind IBEX Limited's NASDAQ-traded stock include a P/E ratio of 11.63 and a market capitalization of 538.2M. Combined with our AI analysis, these give both institutional and retail investors a clear view of IBEX on the NASDAQ.

Price Performance (NASDAQ: IBEX)

1-Day Change
-1.76%
5-Day Change
24.61%
1-Month Change
13.43%
3-Month Change
33.02%
6-Month Change
40.46%
Year-to-Date (YTD) Change
5.29%
1-Year Change
-4.29%
3-Year Change
160.87%
5-Year Change
133.59%
All-Time (Max) Change
161.04%

Contact Information

https://www.ibex.co
202 580 6200
1700 Pennsylvania Avenue NW, Washington, DC, 20006

Company Facts

350,000 Employees
IPO DateAug 7, 2020
CountryUS
Actively Trading

Frequently Asked Questions